Intermarket Industries Inc. dba Doc Ackerman Pet Products

Warning LetterOpen

Greg Mongrain Vice President Intermarket Industries Inc. dba Doc Ackerman Pet Products 1131 Industrial Ave Oxnard , CA 93030 United States gmongrain@juno.comIssued Nov 12, 2024Center for Veterinary Medicine

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations1

Issue DateNov 12, 2024

Product TypeAnimal & Veterinary

StatusOpen

Letter Details

Firm: Intermarket Industries Inc. dba Doc Ackerman Pet Products
Location: Greg Mongrain Vice President Intermarket Industries Inc. dba Doc Ackerman Pet Products 1131 Industrial Ave Oxnard , CA 93030 United States gmongrain@juno.com
FEI Number: N/A
Country: United States
Issue Date: November 12, 2024
Issuing Office: Center for Veterinary Medicine
Product Type: Animal & Veterinary
Status: Open

Summary

Intermarket Industries Inc. dba Doc Ackerman Pet Products marketed an unapproved new animal drug called "Doc Ackerman's - Epilepsy & Seizure Formula" for treating seizures and epilepsy in dogs and cats, in violation of the Federal Food, Drug, and Cosmetic Act. The company promoted the product through Facebook posts and directed customers to purchase it on Amazon and Only Natural Pet Store, making disease treatment claims that classified it as a drug requiring FDA approval. The FDA determined the product was an unapproved new animal drug based on its intended use for disease treatment and mitigation, which is prohibited under section 301(a) of the FD&C Act.

Intermarket Industries Inc. dba Doc Ackerman Pet Products FDA Warning Letter, November 12, 2024